Tesla
TSLA
NVIDIA
NVDA
Alibaba
BABA
4
XPeng
XPEV
5
Apple
AAPL
US Stock MarketDetailed Quotes
RPHCF ROHTO PHARMACEUTICAL CO
- 20.090
- 0.0000.00%
15min DelayClose Dec 31 16:00 ET
4.58BMarket Cap22.88P/E (TTM)
0.000High0.000Low0Volume0.000Open20.090Pre Close0.00Turnover0.00%Turnover Ratio21.88P/E (Static)228.14MShares21.43152wk High2.65P/B4.58BFloat Cap18.30052wk Low0.20Dividend TTM228.14MShs Float26.374Historical High0.98%Div YieldTTM0.00%Amplitude18.300Historical Low--Avg Price1Lot Size
ROHTO PHARMACEUTICAL CO Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 21.08%41.52B | 23.02%34.29B | 21.16%27.87B | 5.87%23.01B | 33.31%21.73B | -3.09%16.3B | 14.02%16.82B | 3.14%14.75B | 4.01%14.3B | -5.81%13.75B |
| Other non cash items | -99.88%5M | 308.30%4.06B | 70.08%-1.95B | -1,419.81%-6.52B | -131.29%-429M | 50.00%1.37B | 139.36%914M | -271.37%-2.32B | -37.27%1.36B | -32.94%2.16B |
| Change In working capital | 21.28%-8.88B | -1,553.22%-11.28B | -77.19%776M | 176.36%3.4B | -1,318.79%-4.46B | 76.07%-314M | -287.97%-1.31B | 107.29%698M | -68.24%-9.58B | -361.13%-5.7B |
| -Change in receivables | 10.22%-6.79B | -25,100.00%-7.56B | -101.22%-30M | 157.25%2.46B | -180.57%-4.3B | 289.57%5.34B | -321.19%-2.82B | 109.66%1.27B | -262.93%-13.19B | -895.62%-3.63B |
| -Change in inventory | 34.00%-4.03B | -122.57%-6.11B | -186.04%-2.74B | 257.40%3.19B | 120.46%892M | -99.41%-4.36B | -164.33%-2.19B | 40.50%-827M | -492.66%-1.39B | 132.48%354M |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | 82.72%-66M | 16.23%-382M | 34.39%-456M | -182.05%-695M | 99.29%847M | 451.24%425M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 10.74%34.25B | 13.48%30.92B | 36.20%27.25B | 5.08%20.01B | -12.44%19.04B | 13.53%21.75B | 42.64%19.15B | 18.58%13.43B | 0.28%11.32B | -39.49%11.29B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | 7.86%-7.71B | 18.44%-8.36B | -26.23%-10.26B | -134.93%-8.12B | 45.81%-3.46B | -27.62%-6.38B | -32.38%-5B | 17.23%-3.78B | -15.11%-4.56B | 36.86%-3.96B |
| Net intangibles purchase and sale | 34.98%-933M | -35.25%-1.44B | 32.98%-1.06B | -86.89%-1.58B | -69.06%-847M | -10.84%-501M | -122.66%-452M | -20.83%-203M | 8.20%-168M | 57.54%-183M |
| Net business purchase and sale | ---- | ---- | 20.65%-1.2B | 73.66%-1.52B | ---5.76B | ---- | ---- | ---- | ---- | -404.74%-3.84B |
| Net investment purchase and sale | -123.58%-7.38B | 9.67%-3.3B | -298.05%-3.65B | 140.10%1.84B | 124.59%768M | 40.36%-3.12B | -2.69%-5.24B | -2,488.32%-5.1B | 57.36%-197M | 84.87%-462M |
| Net other investing changes | 29.21%230M | 39.06%178M | --128M | ---- | 93.10%112M | 23.40%58M | -84.23%47M | 240.57%298M | 21.77%-212M | -240.41%-271M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -23.84%-16.32B | 19.69%-13.18B | -60.26%-16.41B | -8.85%-10.24B | 8.20%-9.41B | 6.98%-10.25B | -15.80%-11.01B | -56.79%-9.51B | 32.78%-6.07B | 28.49%-9.02B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | 87.62%-1.22B | -230.20%-9.88B | 810.07%7.59B | -50.03%834M | 362.42%1.67B | -186.30%-636M | 341.64%737M | 92.18%-305M | -142.02%-3.9B | -171.76%-1.61B |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | -98.88%3M | 9.39%268M | -26.65%245M | 106.30%334M |
| Cash dividends paid | -17.09%-5.48B | -36.65%-4.68B | -15.41%-3.42B | 3.67%-2.97B | -22.83%-3.08B | 0.00%-2.51B | -10.01%-2.51B | 0.00%-2.28B | -11.12%-2.28B | 3.12%-2.05B |
| Net other financing activities | -337.08%-7.09B | -132.23%-1.62B | -223.15%-698M | -16.13%-216M | 23.46%-186M | -523.08%-243M | -95.00%-39M | -158.82%-20M | 170.83%34M | -33.33%-48M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 14.91%-13.78B | -566.83%-16.2B | 247.85%3.47B | -46.41%-2.35B | 52.66%-1.6B | -85.74%-3.39B | 21.93%-1.82B | 60.41%-2.34B | -74.76%-5.9B | 35.23%-3.38B |
| Net cash flow | ||||||||||
| Beginning cash position | 9.57%77.69B | 35.69%70.91B | 16.99%52.25B | 19.60%44.67B | 24.22%37.35B | 28.11%30.06B | 4.32%23.47B | -10.35%22.5B | 8.98%25.09B | 15.90%23.03B |
| Current changes in cash | 167.53%4.14B | -89.18%1.55B | 92.81%14.31B | -7.57%7.42B | -1.01%8.03B | 28.45%8.11B | 299.30%6.32B | 347.19%1.58B | 42.19%-640M | -233.37%-1.11B |
| Effect of exchange rate changes | -10.18%4.7B | 20.78%5.24B | 4,415.63%4.34B | 112.29%96M | 6.13%-781M | -335.60%-832M | 69.83%-191M | 68.32%-633M | -172.00%-2B | 50.08%2.78B |
| End cash Position | 11.42%86.56B | 9.57%77.69B | 35.69%70.91B | 16.99%52.25B | 19.60%44.67B | 24.22%37.35B | 28.11%30.06B | 4.32%23.47B | -10.35%22.5B | 8.98%25.09B |
| Free cash flow | 20.54%25.33B | 31.99%21.02B | 64.08%15.92B | -23.03%9.7B | -14.98%12.61B | 8.22%14.83B | 45.03%13.7B | 43.30%9.45B | -7.73%6.59B | -40.22%7.15B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |